Team (TISI) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
15 Jan, 2026Executive summary
Q3 2024 revenue increased 2% year-over-year to $210.8 million, with U.S. segments up 6% and declines in Canada and international markets.
Operating income improved to $3.2 million from a $1.3 million loss in Q3 2023, driven by higher IHT margins and lower corporate costs.
Net loss for Q3 2024 narrowed to $11.1 million, an 8.3% year-over-year improvement.
Adjusted EBITDA for Q3 was $11.3 million (5.4% margin); for the first nine months, $39.6 million (6.2% margin), up 21% year-over-year.
Free cash flow for Q3 was $3.9 million, a $4.7 million improvement over 2023.
Financial highlights
Q3 2024 revenue: $210.8 million (+2% YoY); nine-month revenue: $639.0 million (-1.5% YoY).
Gross margin for Q3 was 25.4%, with gross profit of $53.5 million.
Adjusted EBITDA for Q3 was $11.3 million; nine-month adjusted EBITDA was $39.6 million, up from $32.8 million in 2023.
Net loss for Q3 was $11.1 million ($2.52/share); nine-month net loss was $31.1 million ($7.04/share).
Free cash flow for the nine months was $(6.3) million, a significant improvement from $(29.5) million in 2023.
Outlook and guidance
FY 2024 revenue guidance revised to $845–$860 million; gross margin $220–$228 million; adjusted EBITDA $53–$55 million.
2025 outlook anticipates low to mid-single-digit revenue growth, improved Canadian operations, and progress toward a 10%+ adjusted EBITDA margin.
Capital expenditures expected at $9–$11 million for 2024.
Management believes current working capital, forecasted cash flows, and available credit are sufficient to fund operations and service debt.
Focus remains on regaining NYSE compliance and maintaining liquidity, with $40.4 million in total liquidity as of November 8, 2024.
Latest events from Team
- 2026 meeting covers director elections, compensation, auditor, warrant issuance, and equity plan.TISI
Proxy filing24 Mar 2026 - Revenue, operating income, and adjusted EBITDA rose, margins improved, and debt was reduced.TISI
Q4 202513 Mar 2026 - Margins and cash flow improved in Q2 2024, with full-year growth and guidance reaffirmed.TISI
Q2 20242 Feb 2026 - Margins and EBITDA improved in 2024, with refinancing extending debt maturities to 2030.TISI
Q4 202426 Dec 2025 - Registering 1.45M shares for resale post-$75M private placement, supporting recapitalization.TISI
Registration Filing16 Dec 2025 - Key votes include director elections, auditor ratification, and a charter amendment on director removal.TISI
Proxy Filing2 Dec 2025 - Annual meeting covers director elections, pay, auditor ratification, and governance updates.TISI
Proxy Filing2 Dec 2025 - Flat Q1 revenue, $29.7M net loss, and refinancing set up at least 15% EBITDA growth for 2025.TISI
Q1 202525 Nov 2025 - Q2 revenue rose 8.5% to $248.0M, Adjusted EBITDA up 12.4%, with margin gains and transformation underway.TISI
Q2 202523 Nov 2025